These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 7193087)

  • 1. Nephrotoxicity of cis-diamminedichloroplatinum(II) as measured by urinary beta-glucuronidase.
    Kuhn JA; Argy WP; Rakowski TA; Moriarty JK; Schreiner GE; Schein PS
    Cancer Treat Rep; 1980; 64(10-11):1083-6. PubMed ID: 7193087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Study on urinary beta-glucuronidase and alkaline phosphatase activities as indicators of CDDP renal toxicity].
    Takahashi T; Yoshida K; Nakame Y; Saitoh H
    Hinyokika Kiyo; 1989 Jan; 35(1):1-6. PubMed ID: 2729012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effects of combination chemotherapy with cis-diamminedichloroplatinum (II) (CDDP) on renal function in patients with urogenital malignancies].
    Kawamura J; Hida S; Higashi Y; Yamauchi T; Soeda A; Yoshida O
    Hinyokika Kiyo; 1985 Feb; 31(2):207-21. PubMed ID: 4040315
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nephrotoxicity of cis-diamminedichloroplatinum with or without ifosfamide in cancer treatment.
    Hacke M; Schmoll HJ; Alt JM; Baumann K; Stolte H
    Clin Physiol Biochem; 1983; 1(1):17-26. PubMed ID: 6383688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective effects of apocynin against cisplatin-induced oxidative stress and nephrotoxicity.
    Chirino YI; Sánchez-González DJ; Martínez-Martínez CM; Cruz C; Pedraza-Chaverri J
    Toxicology; 2008 Mar; 245(1-2):18-23. PubMed ID: 18243469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Nephrotoxicity of contrast media. Comparison of iopamidol and diatrizoate by measurement of urinary enzymes after urography].
    Schiavina G; Arrigo G; Vergnaghi D; Cavaliere G; Scarduelli B; Luzzatti G; D'Amico G
    Radiol Med; 1984 Apr; 70(4):176-9. PubMed ID: 6150520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduction of cis-diamminedichloroplatinum nephrotoxicity in rats by optimal circadian drug timing.
    Levi FA; Hrushesky WJ; Blomquist CH; Lakatua DJ; Haus E; Halberg F; Kennedy BJ
    Cancer Res; 1982 Mar; 42(3):950-5. PubMed ID: 7199382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal complications of cis-diamminedichloroplatinum.
    Nitschke R
    Ann Clin Lab Sci; 1981; 11(5):392-6. PubMed ID: 7199273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of oxidative and nitrosative stress in cisplatin-induced nephrotoxicity.
    Chirino YI; Pedraza-Chaverri J
    Exp Toxicol Pathol; 2009 May; 61(3):223-42. PubMed ID: 18986801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nephrotoxicity of heptaplatin: a randomized comparison with cisplatin in advanced gastric cancer.
    Ahn JH; Kang YK; Kim TW; Bahng H; Chang HM; Kang WC; Kim WK; Lee JS; Park JS
    Cancer Chemother Pharmacol; 2002 Aug; 50(2):104-10. PubMed ID: 12172973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Determination of urinary beta-glucuronidase activity as an expression of renal damage in various forms of kidney diseases in children].
    Rizzoni G; Vegni M; Bedoni D; Tomasina G
    Minerva Pediatr; 1970 Feb; 22(8):398-402. PubMed ID: 4911308
    [No Abstract]   [Full Text] [Related]  

  • 12. Renal handling of cis-diamminedichloroplatinum(II).
    Jacobs C; Kalman SM; Tretton M; Weiner MW
    Cancer Treat Rep; 1980; 64(12):1223-6. PubMed ID: 7193518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of cis-platinum nephrotoxicity: II. Morphologic observations.
    Dobyan DC; Levi J; Jacobs C; Kosek J; Weiner MW
    J Pharmacol Exp Ther; 1980 Jun; 213(3):551-6. PubMed ID: 7193726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urinary beta-glucuronidase in screening and followup of primary urinary tract malignancy.
    Ho KJ
    J Urol; 1995 Oct; 154(4):1335-8. PubMed ID: 7658533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cisplatin nephrotoxicity is mediated by gamma glutamyltranspeptidase, not via a C-S lyase governed biotransformation pathway.
    Wainford RD; Weaver RJ; Stewart KN; Brown P; Hawksworth GM
    Toxicology; 2008 Jul; 249(2-3):184-93. PubMed ID: 18583013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urinary beta-glucuronidase in renal cell carcinoma.
    Rodríguez-Cuartero A; Barcelona-Martín F; Pérez-Blanco FJ
    Clin Nephrol; 2000 Apr; 53(4):288-90. PubMed ID: 10809417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cisplatin-induced nephrotoxicity.
    Meijer S; Sleijfer DT; Mulder NH; Donker AJ
    Neth J Med; 1982; 25(8):262-9. PubMed ID: 6755283
    [No Abstract]   [Full Text] [Related]  

  • 18. [Studies on the mechanisms of renal damages induced by nephrotoxic compounds].
    Yamada T
    Nihon Hoigaku Zasshi; 1995 Dec; 49(6):447-57. PubMed ID: 8583688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of para-aminobenzoic acid on the pharmacokinetics and urinary excretion of cis-diamminedichloroplatinum(II) in rats.
    Esposito M; Vannozzi M; Viale M; Pellecchia C; Civalleri D; Gogioso L
    Anticancer Res; 1995; 15(6B):2541-7. PubMed ID: 8669820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Naringenin attenuates cisplatin nephrotoxicity in rats.
    Badary OA; Abdel-Maksoud S; Ahmed WA; Owieda GH
    Life Sci; 2005 Mar; 76(18):2125-35. PubMed ID: 15826879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.